1Fibula Septa Kumara, 2Atina Hussana, 2Nur Anna C.S.
1Postgraduate student of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
2Postgraduate of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
DOI : https://doi.org/10.47191/ijmra/v6-i11-19Google Scholar Download Pdf
ABSTRACT:
Patients with type 2 DM experience excessive oxidative stress, resulting in hyperglycemia, and increased lipid and DNA modifications. Interaction of bilayer lipids with reactive oxygen produces lipid peroxidases, forming the end product malondialdehyde (MDA). DNA damage is identified by an increase in 8-hydroxydeoxyguanosine (8-OHdG). Curcumin compounds in turmeric extract can inhibit the increase of Reactive Oxygen Species (ROS). This study aims to prove the different effects of metformin, turmeric extract, and the combination of metformin and turmeric extract on blood sugar levels, MDA, and 8-OHdG in male rats (Wistar strain) induced by Streptozotocin-Nicotinamide. This study is experimental with a post-test-only control group design. The research subjects were 24 Wistar rats and were randomly divided into four groups and induced with Streptozotocin-Nicotinamide. KI is the negative control group, KII was given Metformin 45mg/KgBW/day, KIII group was given a Turmeric extract dose of 200mg/KgBW/day, and KIV was given a combination of turmeric extract dose of 100mg/KgBW/day and Metformin 22.5mg/KgBW/day for 14 days. Blood samples in the ophthalmic vein were taken for blood sugar, MDA, and 8-OHdG examination. The decrease in blood sugar, MDA, and 8-OHdG levels in the KIV group was found to be the lowest, followed by KIII, KII, and KI. One Way Anova test on blood sugar levels, MDA, 8-OHdG showed significant differences between groups with a p-value ≤ 0.000. The administration of a combination of metformin and turmeric extract can reduce blood sugar, MDA, and 8-OHdG levels compared with a single dose of Metformin or Turmeric extract.
KEYWORDS:Turmeric extract, blood sugar, MDA and 8-OHdG
REFERENCES1) Soelistijo SA, Lindarto D, Decroli E, Permana H, Sucipto KW, Kusnadi Y, et al. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia 2019. PERKENI [Internet]. 2019;1–117.
2) American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(January):S14–31.
3) Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR, Aguilar RB. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016;39(2):179–86.
4) Ayala A, Muñoz MF, Argüelles S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. 2014
5) Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984 :1–14.
6) Valavanidis, A. Vlachogianni, T. Fiotakis C. 8-hydroxy-2-deoxyguanosine (8-OHdG): A critical biomarker of Oxydative stress and carcinogenesis. 8-hydroxy-2-deoxyguanosine (8-OHdG): A critical biomarker of Oxydative stress and carcinogenesis. 2009: 120–39.
7) Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv. 1053–64.
8) Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy. 2010;18(9):1606–14.
9) Agius L, Ford BE, Chachra SS. The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective. Int J Mol Sci. 2020 May 3;21(9):3240.
10) Kato M, Nishikawa S, Ikehata A, Dochi K, Tani T, Takahashi T, et al. Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol Nutr Food Res [Internet]. 2017 61(3):1600471.
11) Farghadani R, Naidu R. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer. Cancers (Basel). 2021 Jul 8;13(14):3427.
12) Jubaidi FF, Zainalabidin S, Taib IS, Abdul Hamid Z, Mohamad Anuar NN, Jalil J, et al. The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications. Int J Mol Sci. 2022 Aug 2;23(15):8582.
13) Griffiths K, Aggarwal BB, Singh RB, Buttar HS, Wilson D DMF. Food antioxidants and their anti-inflammatory properties: a potential role in cardiovascular diseases and cancer prevention. Food antioxidants and their anti-inflammatory properties: a potential role in cardiovascular diseases and cancer prevention. :4:28.
14) Lv Z, Guo Y. Metformin and Its Benefits for Various Diseases. Front Endocrinol (Lausanne). 2020 Apr 16;11.
15) Hajavi J, Momtazi AA, Johnston TP, Banach M, Majeed M, Sahebkar A. Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes. J Cell Biochem [Internet]. 2017 :4170–82.
16) Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury. Curr Mol Med. 2020 Jan 14;20(2):116–33.
17) Zhao M, Li XW, Chen DZ, Hao F, Tao SX, Yu HY, et al. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress. Medical Science Monitor. 2019 Mar 25;25:2186–94.
Volume 06 Issue 11 November 2023
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 05 (May 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 May 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.